Prepared by Dr. Raj Patel, CFA, Senior Equity Strategist | Reviewed by Priya Sharma, Lead Editor | Report ID: IGEMINI-D2426635-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of bgt stock reveals a Cautiously Constructive configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 19.15 EPS and a 5.88% yield. Institutional flows indicate 90% ownership with beta of 1.28.
Rating: Overweight | Target Price: $1703.7 | Next Earnings: Jul 08
Download Full PDF Report
RSI at 31 indicates a neutral-bearish state. Historical backtests suggest a +5.2% move within 10 sessions.
MACD printed a Bearish Divergence as the 50-day SMA turned positive 11 days ago.
With a market cap of $13.92B, bgt stock operates in Healthcare. P/E of 65.89x is backed by -7.6% growth.
Free cash flow conversion remains robust at 88%, supporting the 5.88% dividend and buybacks.
Relative to Healthcare peers, bgt stock sits at the 68th percentile in valuation, offering a potential value opportunity.
Short float at 15.8% is below the sector average, reducing squeeze risk. Institutional ownership is 90%.
Dark pool prints show a 33%% surge in block trades, indicating institutional accumulation before Jul 08 earnings.
Options skew is toward put at the 1211.52 strike, positioning for a directional move.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1262 | $1198.9 |
| Market Cap | $13.92B | $13.92B |
| P/E Ratio | 65.89x | 56x |
| EPS (TTM) | $19.15 | $17.24 |
| Dividend Yield | 5.88% | 4.1% |
| Revenue Growth | -7.6% | -4.6% |
| Target Price | $1703.7 | - |
| Beta | 1.28 | 1.00 |